Announce Date | 05/06/2025 |
EPS Normalized Actual | $2.32 (Beat by $0.07) |
EPS GAAP Actual | $2.32 (Beat by $0.07) |
Revenue Actual | $6.263B |
Revenue Surprise | Beat by $6263M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.87506 |
EPS GAAP Estimate | $2.87506 |
Revenue Estimate | $6.863801983B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 17.45 | 16.05 | 16.57133 | 18.3187 | 1 |
Dec 2028 | 16.82 | 16.65 | 15.9608 | 17.67747 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.4 | 2.4 | 6.263B | 56.03% | 6263M |
FQ4 2024 (Dec 2024) | 0 | 0 | 6.429B | 5.2% | 6429M |
FQ3 2024 (Sep 2024) | 2.08 | 2.08 | 6.255B | 56.29% | 6255M |
FQ2 2024 (Jun 2024) | 2.7 | 2.7 | 3.054B | 6.09% | 3054M |
FQ1 2024 (Mar 2024) | 1.94 | 1.94 | 2.754B | 5.56% | 2754M |
FQ4 2023 (Dec 2023) | 0 | 0 | 6.095B | 99.29% | 6095M |
FQ3 2023 (Sep 2023) | 2.52 | 2.52 | 2.734B | -94.33% | 2734M |
FQ2 2023 (Jun 2023) | 2.39 | 2.39 | 2.868B | 87.31% | 2868M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.87506
Consensus Revenue Estimates
6.863801983B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.2268 | -- | 3.13974 | 3.31492 | 5 |
FQ3 2027 (Sep 2027) | 3.14928 | -- | 3.06431 | 3.23528 | 5 |
FQ2 2027 (Jun 2027) | 3.40623 | -- | 3.31433 | 3.49925 | 5 |
FQ1 2027 (Mar 2027) | 2.74782 | -- | 2.67368 | 2.82286 | 5 |
FQ4 2026 (Oct 2026) | 2.95994 | -- | 2.73234 | 3.14019 | 5 |
FQ3 2026 (Jul 2026) | 3.11778 | -- | 2.87805 | 3.30764 | 5 |
FQ2 2026 (Jun 2026) | 3.18295 | -- | 3.08269 | 3.3052 | 5 |
FQ1 2026 (Mar 2026) | 2.69925 | 11.09 | 2.61422 | 2.80292 | 11 |
FQ4 2025 (Oct 2025) | 2.7278 | -- | 2.51805 | 2.89391 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 7.5B | -- | 7.35B | 7.66B | 9 |
FQ3 2027 (Sep 2027) | 7.4B | -- | 7.25B | 7.56B | 9 |
FQ2 2027 (Jun 2027) | 7.3B | -- | 7.15B | 7.45B | 9 |
FQ1 2027 (Mar 2027) | 7.2B | -- | 7.05B | 7.35B | 9 |
FQ4 2026 (Oct 2026) | 1.77B | -- | 1.67B | 1.86B | 5 |
FQ3 2026 (Jul 2026) | 1.79B | -- | 1.68B | 1.87B | 5 |
FQ2 2026 (Jun 2026) | 1.79B | -- | 1.75B | 1.84B | 4 |
FQ1 2026 (Mar 2026) | 1.68B | -272.94 | 1.64B | 1.73B | 7 |
FQ4 2025 (Oct 2025) | 6.69B | 3.84 | 6.29B | 7B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.4 | 2.4 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 2.08 | 2.08 | 100% | |
FQ2 2024 (Jun 2024) | 2.7 | 2.7 | 100% | |
FQ1 2024 (Mar 2024) | 1.94 | 1.94 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 2.52 | 2.52 | 100% | |
FQ2 2023 (Jun 2023) | 2.39 | 2.39 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $6.26B | $6263M | 100% |
FQ4 2024 (Dec 2024) | $0B | $6.43B | $6429M | 100% |
FQ3 2024 (Sep 2024) | $0B | $6.26B | $6255M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.05B | $3054M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.75B | $2754M | 100% |
FQ4 2023 (Dec 2023) | $0B | $6.1B | $6095M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.73B | $2734M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.87B | $2868M | 100% |